{"id":35027,"date":"2015-04-23T09:06:49","date_gmt":"2015-04-23T13:06:49","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=35027"},"modified":"2015-04-23T09:06:49","modified_gmt":"2015-04-23T13:06:49","slug":"enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027","title":{"rendered":"Enzon Pharmaceuticals Inc (NASDAQ:ENZN) \u2013 Wait For A Firm Close Above $1.90"},"content":{"rendered":"<p style=\"text-align: justify;\"><strong>Enzon Pharmaceuticals Inc (NASDAQ:ENZN)<\/strong>, a company in the business of licensing drug products, usually would not be on the radar of the investors but a rise of 77% in the current month definitely makes it a name worthy of some attention. The last trading session saw an insane number of shares changing hands, pushing the volume for the day to 35 million which was huge compared to the daily average of 3 million only. The stock had opened with a gap down but in the closing hours, the bulls took the control and ended the session with a gain of 13%.<\/p>\n<p style=\"text-align: justify;\">Enzon Pharmaceuticals Inc (NASDAQ:ENZN) rose over 32% in the last 12 months, outperforming the broader indices by a huge margin. The probable reason for that strong performance comes from the improved financials of the company like the last reported quarterly earnings per share seeing an increase of 8.3% compared to the same quarter in the previous year. The bottom line improved from $0.39 to $0.65. The revenue dropped by 15.6% compared to the same quarter in the previous year, a serious underperformance compared to the industry average of 35.1%. Still, the improved earnings per share saved the bottom line from being hurt by the declining revenue.<\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/ENZN.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\" size-full wp-image-35028 aligncenter\" src=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/ENZN.jpg\" alt=\"ENZN\" width=\"633\" height=\"467\" srcset=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/ENZN.jpg 633w, https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/ENZN-300x221.jpg 300w, https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/ENZN-75x55.jpg 75w\" sizes=\"(max-width: 633px) 100vw, 633px\" \/><\/a><\/p>\n<p style=\"text-align: justify;\">Technically, the major trend for the stock has been nothing but down in the last few years but the bearish momentum has slowed down a lot in the last 1 year. The stock is stuck in the range of $0.80-$1.90 for a long time and as long as the stock closes below $1.90, the investors actually can\u2019t hope for much. The record volume seen in the last trading session has definitely interested the market participants but it will become meaningless below $1.90. Cautious investors may keep an eye on the stock and wait for a firm closing before taking positions.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Enzon Pharmaceuticals Inc (NASDAQ:ENZN), a company in the business of licensing drug products, usually would not be on the radar of the investors but a [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":35029,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[11262,11263],"stock_ticker":[],"class_list":["post-35027","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-enzon-pharmaceuticals-inc-nasdaqenzn","tag-nasdaqenzn","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Enzon Pharmaceuticals Inc (NASDAQ:ENZN) \u2013 Wait For A Firm Close Above $1.90 - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Enzon Pharmaceuticals Inc (NASDAQ:ENZN) \u2013 Wait For A Firm Close Above $1.90 - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Enzon Pharmaceuticals Inc (NASDAQ:ENZN), a company in the business of licensing drug products, usually would not be on the radar of the investors but a [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2015-04-23T13:06:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/Enzon.png\" \/>\n\t<meta property=\"og:image:width\" content=\"259\" \/>\n\t<meta property=\"og:image:height\" content=\"194\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Donna Fago\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Donna Fago\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027\"},\"author\":{\"name\":\"Donna Fago\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\"},\"headline\":\"Enzon Pharmaceuticals Inc (NASDAQ:ENZN) \u2013 Wait For A Firm Close Above $1.90\",\"datePublished\":\"2015-04-23T13:06:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027\"},\"wordCount\":307,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/Enzon.png\",\"keywords\":[\"Enzon Pharmaceuticals Inc (NASDAQ:ENZN)\",\"NASDAQ:ENZN\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027\",\"name\":\"Enzon Pharmaceuticals Inc (NASDAQ:ENZN) \u2013 Wait For A Firm Close Above $1.90 - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/Enzon.png\",\"datePublished\":\"2015-04-23T13:06:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/Enzon.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/Enzon.png\",\"width\":259,\"height\":194},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Enzon Pharmaceuticals Inc (NASDAQ:ENZN) \u2013 Wait For A Firm Close Above $1.90\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84\",\"name\":\"Donna Fago\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg\",\"caption\":\"Donna Fago\"},\"description\":\"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.\",\"sameAs\":[\"http:\/\/www.WallStreetPR.com\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Enzon Pharmaceuticals Inc (NASDAQ:ENZN) \u2013 Wait For A Firm Close Above $1.90 - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027","og_locale":"en_US","og_type":"article","og_title":"Enzon Pharmaceuticals Inc (NASDAQ:ENZN) \u2013 Wait For A Firm Close Above $1.90 - Wall Street PR","og_description":"Enzon Pharmaceuticals Inc (NASDAQ:ENZN), a company in the business of licensing drug products, usually would not be on the radar of the investors but a [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2015-04-23T13:06:49+00:00","og_image":[{"width":259,"height":194,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/Enzon.png","type":"image\/png"}],"author":"Donna Fago","twitter_misc":{"Written by":"Donna Fago","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027"},"author":{"name":"Donna Fago","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84"},"headline":"Enzon Pharmaceuticals Inc (NASDAQ:ENZN) \u2013 Wait For A Firm Close Above $1.90","datePublished":"2015-04-23T13:06:49+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027"},"wordCount":307,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/Enzon.png","keywords":["Enzon Pharmaceuticals Inc (NASDAQ:ENZN)","NASDAQ:ENZN"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027","url":"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027","name":"Enzon Pharmaceuticals Inc (NASDAQ:ENZN) \u2013 Wait For A Firm Close Above $1.90 - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/Enzon.png","datePublished":"2015-04-23T13:06:49+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/Enzon.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2015\/04\/Enzon.png","width":259,"height":194},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/enzon-pharmaceuticals-inc-nasdaqenzn-wait-for-a-firm-close-above-1-90-35027#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Enzon Pharmaceuticals Inc (NASDAQ:ENZN) \u2013 Wait For A Firm Close Above $1.90"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/60ece280249b1fa366ae54f87bb8ae84","name":"Donna Fago","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/f15db860f556e28a86f628554c98485b.jpeg","caption":"Donna Fago"},"description":"I believe in writing content Informing investors with the knowledge they need to invest better today- I have been following the markets for many years and was asked to join the team at WallStreetPR.com recently due to my passion for the markets.","sameAs":["http:\/\/www.WallStreetPR.com"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/darcie-fago"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/35027","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=35027"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/35027\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/35029"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=35027"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=35027"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=35027"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=35027"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}